Pinnacle Advisory Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Pinnacle Advisory Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5,010	Closed	-$229K	–	150
2014 Q4	$229K	Hold	5,010	–	–	0.02%	127
2014 Q3	$229K	Buy	+5,010	New	+$435K	0.03%	109
2014 Q2	–	Sell	-5,375	Closed	-$246K	–	130
2014 Q1	$246K	Hold	5,375	–	–	0.02%	89
2013 Q4	$246K	Buy	+5,375	New	+$353K	0.03%	77
2013 Q3	–	Sell	-5,375	Closed	-$246K	–	104
2013 Q2	$246K	Buy	+5,375	New	+$307K	0.03%	69

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Pinnacle Advisory Group's FBT Position: Q1 2015 in Review

Pinnacle Advisory Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2015, closing a stake of 5,010 shares — an estimated $229K sold.

Pinnacle Advisory Group first reported a position in FBT in Q2 2013 and held it in 5 quarters. The position peaked at $246K in Q1 2014. 122 funds tracked by Wall St. Rank hold FBT as of Q1 2015.

Pinnacle Advisory Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2015 after selling out during the quarter.
Pinnacle Advisory Group sold 5,010 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2015, an estimated $229K.
Pinnacle Advisory Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 5 quarters.
Pinnacle Advisory Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $246K in Q1 2014.
122 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2015.

Based on Pinnacle Advisory Group's 13F filing for Q1 2015, filed 1 May 2015.